Efficacy of treatment with lamivudine in patients with chronic active E-minus variant hepatitis B virus infection: A nonrandomized, open-label study
Authors:
- Gaetano ScottoGSGaetano Scotto
- Vincenzina FazioVFVincenzina Fazio
- Fausto CampanozziFCFausto Campanozzi
- Antonio D'AdduzioADAntonio D'Adduzio
- 30 June 2000
- journal article
- Published by Elsevier in Current Therapeutic Research
- Vol. 61 (6) , 321-330
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Lamivudine therapy for chronic hepatitis B: A six-month randomized dose- ranging studyGastroenterology, 1997
- Long-Term Follow-up of HBeAg-Positive Patients Treated with Interferon Alfa for Chronic Hepatitis BNew England Journal of Medicine, 1996
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995
- Phase II trial of lamivudine for chronic hepatitis BHepatology, 1993
- Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis BAnnals of Internal Medicine, 1993
- Precore mutant hepatitis B virus infection and liver diseaseGastroenterology, 1992
- Prevalence and type of pre-C HBV mutants in anti-HBe positive carriers with chronic liver disease in a highly endemic areaVirology, 1991
- Hepatitis B: global importance and need for controlVaccine, 1990
- Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type BJournal of Hepatology, 1990
- The development of cirrhosis in patients with chronic type B hepatitis: A prospective studyHepatology, 1988